The accumulation of macrophages in the vascular wall is a hallmark of atherosclerosis. The biological properties of atherosclerotic plaque macrophages determine lesion size, composition, and stability. In atherosclerotic plaques, macrophages encounter a microenvironment that comprises a variety of lipid oxidation products, each of which has diverse biological effects. In this review, we summarize recent advances in our understanding of the effects of plaque lipids on macrophage phenotypic polarization.
Introduction
Distinguishable macrophage phenotypes, M1 and M2, have been observed in the course of inflammatory reactions [1] . Upon activation by IFNg and LPS, M1 macrophages secrete inflammatory factors TNFa, IL1b, IL6, and IL12 that incite a Th1 immune response. M1 macrophages also produce reactive oxygen and nitrogen species and upregulate COX2, which leads to the production of eicosanoids. As inflammation proceeds, IL10, IL4, and IL13 alternatively activate macrophages toward an M2 phenotype with anti-inflammatory functionality, including the production of IL10, TGFb1, and arginase 1 [1]. A macrophage phenotype isolated during the resolution phase of inflammation (Mres) has been characterized by elevated cAMP levels and shares attributes of both M1 and M2 [2] . The development of macrophage phenotypes is under transcriptional control. The NF-kB pathway directs activation of M1 whereas PPARg directs M2. The recently discovered macrophage phenotype, Mox, develops in response to oxidized phospholipids involving the redox-sensitive transcription factor NF-E2-related factor 2 (Nrf2) [3 ] .
Macrophages play a key role in the development of atherosclerotic lesions [4] . The presence of distinguishable macrophage phenotypes in atherosclerotic plaques has been reviewed recently [5] [6] [7] . Subpopulations of proinflammatory and anti-inflammatory macrophages were identified in human lesions [8, 9] and in advanced atherosclerotic lesions of low density lipoprotein receptor (LDL-R) null mice, where the relative abundance of macrophage phenotypes was found to be 40% M1, 30% Mox, and 20% M2 [3 ] . However, mechanisms that control macrophage polarization in atherosclerosis are just beginning to be understood. to be readily recruited to atherosclerotic lesions [10, 11] and to develop into M1 macrophages. Interestingly, C-reactive protein was shown to induce polarization of monocytes toward M1 [12] . Studies in humans have shown that treatment with ligands specific for PPARg primes monocytes to become M2 macrophages in atherosclerotic lesions [9] . Notably, low-intensity exercise by sedentary individuals also primed circulating monocytes toward an M2 phenotype by a mechanism that involved PPARg [13] .
Macrophage phenotypic polarization also occurs in response to changes in the tissue microenvironment: a macrophage phenotype characterized by elevated expression of CD163, a scavenger receptor for hemoglobin-haptoglobin complexes, was shown to develop in response to intraplaque hemorrhage perhaps as part of a mechanism to protect against atherosclerotic lesion destabilization [14] . The importance of controlling hemecatabolism is further underlined by the finding that iron overload induced an unrestrained proinflammatory M1 phenotype [15] .
In addition to various interleukins and cytokines, atherosclerotic plaques contain a plethora of bioactive lipid species that potentially regulate macrophage phenotypic polarization and function. Cholesterol has been observed to crystallize in the core of plaques and induce proinflammatory signaling pathways in this form. Sphingolipids can be released from cells or found associated with HDL. Lysophospholipids and fatty acids can be released from LDL via phospholipases. Prostaglandins and leukotrienes [16] are formed from arachidonic acid while omega-3 fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are precursors to resolvins and protectins. Moreover, the microenvironment in atherosclerotic lesions is characterized by increased oxidative tissue damage and accumulation of oxidatively modified lipids. Isoprostanes, which are formed by free radical-induced oxidation of arachidonic acid, are useful biomarkers and potentially modulate inflammation in atherosclerotic plaques [17] . Oxysterols can be present as a byproduct of cholesterol metabolism, which can be quite dysfunctional in lipid laden foam cells [18] . Additionally, oxidized phospholipids can be presented on minimally modified LDL (MM-LDL) and on the membranes of apoptotic cells, from which they are shed in microvesicles and apoptotic blebs.
This review will focus on how bioactive lipids in the plaque microenvironment affect proinflammatory and anti-inflammatory signaling to determine phenotypic polarization and consequently biological function of macrophages in atherosclerosis ( Fig. 1 ).
Macrophage phenotypic polarization in response to proinflammatory lipid mediators
Oxidatively modified lipids and lipoproteins resemble 'danger signals' that are recognized by pattern recognition receptors such as TLR2 and TLR4. Moreover, CD36, a scavenger receptor that binds oxidized LDL, has been shown to act in combination with certain TLR heterodimers, mediating proinflammatory effects of oxidized lipoproteins and lipids [19, 20] . Accumulating evidence supports a role for toll-like receptors (TLRs) in the pathogenesis of atherosclerosis, and TLR activation in macrophages by lipids induces NF-kB-dependent, MAP kinase-dependent, and ROS-dependent inflammatory gene expression, producing an M1-like phenotype. In addition, activation of the inflammasome and other stress-response mechanisms result in a proinflammatory phenotype in plaque macrophages.
Oxidized lipoproteins
In atherosclerosis, peripheral blood monocytes are recruited to the vessel wall where they differentiate into macrophages and develop into foam cells through the ingestion of lipids [4] . Accumulation of oxidized LDL (oxLDL) in M2 macrophages drives these cells toward a proinflammatory state accompanied by downregulation of the anti-inflammatory transcription factor KLF2 [21] . MM-LDL was shown to activate macrophages via TLR4 through the recruitment and activation of spleen tyrosine kinase (Syk) and protein kinase C which resulted in intracellular generation of ROS by NADPH oxidase 2 (gp91phox/Nox2) [22] . Nox2 was required for the expression of inflammatory cytokines including IL-1b and RANTES/CCL5. MM-LDL was shown to activate TLR signaling by inducing a redistribution of CD14, TLR4, and TLR2 in the macrophage membrane [23] and MM-LDL cooperatively activated TLR4 with low-dose LPS [24] . Further evidence for an involvement of TLR4 in mediating effects of modified lipoproteins comes from a study where lipoproteins isolated from zebrafish larvae that had been fed a high-fat diet (HFD), induced MAP kinase signaling and cell spreading in wild type, but not in TLR4-deficient murine macrophages [25 ] . It was shown that Nrf2-dependent antioxidant signaling counteracts LPS-induced inflammation in foam cells [33] via mechanisms that included upregulation of hemeoxygenase-1 (HO-1), a marker for Mox macrophages [3 ] . However, recent findings point to a role for Nrf2 in mediating inflammatory responses in addition to antiinflammatory processes. In support of this concept, it was shown that Nrf2 deficiency was protective in models of experimental atherosclerosis [34] [35] [36] . A possible mechanism underlying these seemingly paradoxical findings may involve a role for Nrf2 in activation of the inflammasome [34] . In fact, the proatherogenic activity of Nrf2 may be caused by cholesterol crystals, which have been shown to activate the NLRP3 inflammasome in a Nrf2dependent manner [34] .
Cholesterol crystals
Crystallization of cholesterol was thought to be a late event in atherosclerosis and thus would not contribute to the initiating inflammatory events. However, a recent ?
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Oxidized cholesteryl esters
In the core of LDL, cholesterol is esterified with fatty acids. Cholesteryl esters containing unsaturated acyl chains can be oxidatively modified, leading to the formation of biologically active compounds that activate macrophages [39, 40] . Cholesteryl linoleate induces inflammatory signals in macrophages in a MAP kinase pathway-dependent fashion [25 ,41] . Another cholesteryl ester, 7-ketocholesteryl-9-carboxynonanoate was shown to induce NF-kB signaling in macrophages [42] . Recent studies have shown that oxidized cholesteryl esters can trigger inflammatory signaling and foam cell formation via pinocytosis by a process that involves TLR4 [22, 43] . Clearly, cholesteryl esters are capable of inducing inflammatory signals; however, other cholesteryl esters such as 9-oxononanoyl-cholesterol are able to induce expression of anti-inflammatory mediators such as TGFb [44] .
Oxidized cholesteryl esters and oxidized phospholipids may play an important combined role in the regulation of foam cell formation. Cholesteryl ester hydroperoxides increase the expression of the scavenger receptor CD36 by macrophages [45] . Certain oxidized phospholipids that are ligands for CD36 and also the scavenger receptor class B, type 1 (SR-B1) were shown to interfere with SR-B1-mediated selective uptake of cholesteryl esters [46] . A link between phenotypic polarization and foam cell formation was provided by a recent study that showed that activation of aMb2 integrins prevented alternative macrophage activation and foam cell formation by inhibiting CD36 expression [47] .
Oxysterols
Originally believed to be cytotoxic by-products of cholesterol metabolism, recent findings demonstrate that oxysterols, as ligands of liver X receptors (LXR), potently modulate lipid metabolism and inflammation (recently reviewed in [18] ). Oxysterols may also have effects on macrophages that are independent of LXR. ORP9 is an oxysterol binding protein that is upregulated in oxLDLstimulated peripheral blood monocytes [48] . Moreover, treatment of Thp-1 macrophages with 7-keto-cholesterol or a mixture of oxysterols induced expression of MCP-1 [49] . Additionally, oxysterols caused expression of the scavenger receptor CD36 via a GPCR/Src/PLC/PKCd/ ERK-dependent mechanism that resulted in PPARg upregulation [50] .
Lysophospholipids and fatty acids
The action of phospholipases on lipoproteins and membrane phospholipids results in release of lysophospholipids and free fatty acids. A recent study showed that modification of LDL by group V PLA2 results in products that activate macrophages to secrete TNFa and IL6 via NF-kB activation in addition to enhancing lipid uptake and foam cell formation [51] . An acidic environment, as would be found in advanced atherosclerotic plaques, enhances the inflammatory activity of lysophosphatidylcholine (lysoPC) and free fatty acids by impairing the ability of albumin to sequester those products [52] . The G-protein coupled receptor G2A mediates the ability of lysoPC to induce signaling and chemotaxis in macrophages [53] [54] [55] . Moreover, G2A may be a receptor for oxidized fatty acids [56] . Recently, two splice variants of G2A were described, both of which recognized 9-HODE [57] . Interestingly, deficiency of G2A was shown to promote an inflammatory phenotype in macrophages, resembling an M1 macrophage. This was characterized by increased nuclear translocation of NF-kB, and IL6, and IL12 expression, as well as reduced Arginase 1 [58] . Global and myeloid cell-specific G2A deficiency were shown to have profound effects on atherosclerosis development [58] [59] [60] .
Proatherogenic effects have been attributed to saturated fatty acids. Palmitic acid promotes foam cell formation by macrophages by the upregulation of oxLDL receptor 1 (LOX1), possibly by inducing ER stress [61] , an effect counteracted by unsaturated fatty acids. Several studies indicate that saturated free fatty acids may be ligands for TLR2 and TLR4, causing NF-kB-dependent inflammatory gene expression and thereby contributing to atherosclerosis, inflamed adipose tissue, and insulin resistance [62] [63] [64] . Moreover, palmitate and stearate in the presence of high glucose increase expression of TLR2 and TLR4 on monocytes, causing ROS generation and increased NF-kB activity [62] . Debate continues as to whether saturated fatty acids directly bind to and activate TLRs [65] .
Macrophage phenotypic polarization in response to anti-inflammatory and proresolving lipid mediators
Several lipid mediators that are present in atherosclerotic plaques were shown to polarize macrophages toward antiinflammatory and proresolving phenotypes. For instance, oxidized lipids were described to have numerous anti-inflammatory effects [66] and omega-3 fatty acidderived products, resolvins, and protectins, have been shown to play important roles in the resolution of inflammation [67] .
Polyunsaturated fatty acids and nitro-fatty acids
Unlike saturated fatty acids, polyunsaturated fatty acids (PUFAs) can evoke anti-inflammatory mechanisms in macrophages. Unsaturated fatty acids often counteract inflammatory pathways induced by saturated fatty acids; for example, in macrophages PUFAs suppress palmitic acid-induced increases in LOX1 and FABP expression [67, 68] . Conjugated linoleic acid has been shown to cause regression of pre-established murine atherosclerotic plaques, accompanied by decreased lesion macrophage accumulation and suppressed COX2, cPLA2, MCP1, and MMP9 expression in macrophages [69] .
Another class of anti-inflammatory unsaturated fatty acid products are electrophilic nitro-fatty acids, which are formed via nitric oxide or nitrite-dependent redox reactions [70] . Nitro-fatty acids have been shown to activate Nrf2 and PPARg [71] [72] [73] . The anti-inflammatory activity of nitro-fatty acids has been shown in vitro as well as in a cardiac ischemia reperfusion model in vivo [70, 74, 75] . Recently, it was shown that nitro-fatty acids also exert antiatherosclerotic effects: subcutaneous injection of nitro-oleic acid resulted in a significant reduction of lesion formation in apoE null mice without affecting serum lipid levels. Furthermore, atherosclerotic lesions of nitro-oleic-acid-treated mice showed increased collagen content and stability [76 ] .
Omega-3 fatty acids and resolvins
Omega-3 fatty acids have long been known to have antiatherogenic effects. A recent study of carotid endarterectomy patients who consumed omega-3-polyunsaturated fatty acid capsules for 21 days leading up to surgery had more stable plaques that were less inflamed with fewer T cells and fewer foam cells [77] . Macrophages in atherosclerotic plaques of obese/LDL-R À/À mice showed defective phagocytosis of apoptotic cells that was reversed by supplementation of omega-3 fatty acids EPA and DHA [78] . Moreover, action of COX-2 on omega-3-fatty acids was shown to produce potent antiinflammatory products [79] .
Macrophages themselves can produce a class of DHAderived anti-inflammatory and proresolving products, the maresins (macrophage mediator in resolving inflammation) [80] . Lipoxin A4, aspirin-triggered lipoxin A4, resolvin E1/D1/D2, and maresin 1 all enhance phagocytosis of apoptotic neutrophils by macrophages without inducing inflammatory gene expression. Chem23 was shown to be a receptor for some resolvins [81] . Effects of these mediators in atherosclerotic plaques have been implied [82, 83] . Peripheral artery disease (PAD) patients had significantly lower plasma levels of aspirin-triggered lipoxin than healthy volunteers. Further investigation showed that aspirin-triggered lipoxin and resolvin E1 likely effect the migration of vascular smooth muscle cells in PAD [82] .
Sphingosine-1-phosphate
Sphingosine-1-phosphate (S1P) has been shown to induce an anti-inflammatory phenotype in macrophages via S1P receptor 1 (S1PR1) [84] . Additionally, some antiatherogenic effects of high-density lipoproteins are mediated by S1PR1 [85] . However, recent evidence suggests that other S1P receptors (S1PR2) may mediate proatherogenic effects. ApoE/S1PR2 null mice have smaller plaques, decreased macrophage density, and decreased proinflammatory cytokines. ApoE/S1P2 null macrophages show decreased activity of ROCK/NF-kB, reduced cytokine expression, and decreased oxLDL uptake [86, 87] .
Open questions: functional consequences of lipid-induced macrophage phenotypic polarization in plaques
With so many bioactive lipids present in atherosclerotic plaques, it is important to more clearly define their effects on plaque macrophages. Moreover, elucidating the time course of the appearance and action of different lipid mediators will help us better understand the progress of atherosclerosis as well as the mechanisms that are involved in resolution.
Beyond the development of different capacities to regulate inflammation, little is known about functional changes resulting from macrophage phenotypic polarization. What are the migratory properties and phagocytotic capacities of the different phenotypes? In the context of atherosclerosis, it is important to further elucidate the capabilities of different macrophage phenotypes to form foam cells. How might phenotypic polarization alter reverse cholesterol transport and lipid metabolism? Future studies will shed more light on these important properties of different macrophage phenotypes that are present in atherosclerotic lesions.
Conclusion
The plaque environment contains many different lipid mediators that drive macrophage phenotypic polarization. Some lipids activate the inflammasome or act via pattern recognition receptors to induce inflammatory programmes in macrophages or enhance the formation of foam cells. Other lipids incite stress responses in macrophages that enhance antioxidant and detoxifying actions. Yet other lipids such as S1P and oxysterols have both inflammatory and anti-inflammatory effects.
The relative abundance of various macrophage phenotypes may determine the outcome of an inflammatory reaction [5] . Chronic inflammation in atherosclerosis resembles an unresolved inflammatory response where M1 and Mox macrophages outnumber M2 macrophages [3 ,88] . Shifting the balance from proinflammatory toward anti-inflammatory, possibly proresolving macrophages could be a therapeutic strategy to initiate resolution in atherosclerotic plaques and in chronically inflamed tissues in general. In support of this hypothesis, it was shown that during plaque regression, induced by increased HDL or decreased serum cholesterol levels, macrophages switch their phenotype to the anti-inflammatory M2 type [89, 90] .
Among compounds or treatment strategies that can either prime circulating monocytes or induce the transition of a proinflammatory macrophage into M2 macrophages are thiazolidinediones (TZDs) [9] , adiponectin [91] , FK 506 (tacrolimus) [92] , the S1P analogue FTY 720 [93] , cordycepin (a component of cordyceps militaris) and adenosine [94] , inhibition of CD40-CD40 ligand signaling [95] , as well as exercise [13] . Some studies suggest that LXR ligands, conjugated linoleic acid, and PUFAs could switch macrophages into an anti-inflammatory, possibly proresolving phenotype. Drugs commonly taken by patients suffering from cardiovascular disease include aspirin and statins, which modify COX2 via acetylation or S-nitrosylation, respectively, and this process drives the generation of aspirin-triggered lipoxins, namely 15-epi-LXA4, which may establish and carry forward the resolution of inflammation [81, 96] .
Macrophage phenotypic polarization and its connection to plaque lipids is an important aspect of lesion development and progression. A better understanding of the complex microenvironment and the multiple biological processes in atherosclerotic lesions that control macrophage function will lead to novel treatment strategies.
